Tag: Novo Nordisk

CagriSema May Not Be Enough to Restore Novo Nordisk’s Obesity Lead

Novo Nordisk did not lose momentum because CagriSema is a weak drug. That is too simple. The sharper problem is that CagriSema is being asked to solve a…